Amgen (AMGN) Price to Book (2009 - 2026)

Amgen has reported Price to Book for 18 years, with the latest figure at 16.75 in Q2 2026.

• On a quarterly basis, Price to Book fell 17.22% year-over-year to 16.75 in Q2 2026; TTM through Jun 2026 was 16.75, a 17.22% decrease from a year earlier, with the FY2025 full-year figure at 20.37, down 14.46% from the prior year.
• Price to Book was 16.75 for Q2 2026 at Amgen, down from 20.66 in the prior quarter.
• The five-year high for Price to Book was 141.03 in Q1 2022, with the low at 15.8 in Q3 2025.
• Average Price to Book over 5 years is 32.09, with a median of 23.98 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Price to Book soared 819.62% in 2022, then slumped 82.87% in 2023.
• Over 5 years, Price to Book stood at 38.31 in 2022, then slumped by 35.41% to 24.74 in 2023, then fell by 3.77% to 23.81 in 2024, then fell by 14.46% to 20.37 in 2025, then retreated by 17.77% to 16.75 in 2026.
• The last three Price to Book figures came in at 16.75 (Q2 2026), 20.66 (Q1 2026), and 20.37 (Q4 2025), per Business Quant data.